Lead the development and execution of clinical biomarker plans aligned with Caribou’s clinical development strategy
Familiarity with preparing, updating, and finalizing documentation for regulatory submissions such as biomarker-related sections in Clinical protocols, Investigator Brochures, Clinical Study Reports and other related clinical biomarker related documents
Lead biomarker-related activities across all phases of clinical trials, ensuring alignment with study objectives, timelines, and budget
Organize, analyze results, interpret emerging clinical biomarker data, and communicate effectively at research and cross-functional meetings and senior management
Participate in program development teams and lead pertinent translational research working groups
Oversee the discovery, validation, and qualification of biomarkers and methods to inform mechanism of action, response/resistance, safety as well as disease monitoring, and treatment response evaluation of Caribou’s allogeneic cell therapy drug products
Liaise and support cross-functional translational research teams including computational biology, clinical teams and lab scientists for biomarker analysis, back-translation and exploration of translational strategies such as indication or patient selection
Requirements
Ph.D. in Oncology/Immunology or related field with 5+ years of industry experience and 3+ years in oncology/biomarkers/translational or correlative research
Ability to develop and execute biomarker plans aligned with overall clinical development goals and corporate objectives
Demonstrated experience in designing and leading clinical biomarker components of phase I-III clinical trials in the biopharmaceutical industry
Familiarity with interpreting and integrating biomarker data to drive decision-making in clinical trials.
Familiarity with multiple myeloma regulations and clinical biomarkers including but not limited to PK/PD/MRD assays
Understanding of regulatory requirements and guidelines related to biomarker development and utilization in cell therapy clinical trials (e.g., FDA, EMA, ICH guidelines)
Experience in designing and execution of translational research, in-vitro and in-vivo pharmacology, and mechanism of action studies is preferred
Experience in managing external vendors and biomarker operations
Excellent written and verbal communication skills, including the ability to present complex biomarker data effectively to diverse audiences, including internal teams and senior management, external stakeholders, and regulatory agencies
Familiarity with cell therapy and multiple myeloma landscapes, including competitive products, emerging trends, and current challenges
Able to adapt to a dynamic and rapidly changing company environment, and to adjust their workload according to shifting priorities
Benefits
Comprehensive compensation package, which includes competitive salary, bonus, and equity for all employees
Generous paid vacation time, in addition to company-observed holidays
Excellent medical, dental, and vision insurance
401(k) retirement savings plan, which includes matching employer contributions
Employee stock purchase plan (ESPP)
Tuition reimbursement program
Applicant Tracking System Keywords
Tip: use these terms in your resume and cover letter to boost ATS matches.
Hard skills
biomarker developmentclinical trial designtranslational researchin-vitro pharmacologyin-vivo pharmacologymechanism of action studiesregulatory submissionsbiomarker data analysisPK/PD/MRD assaysclinical protocols
Soft skills
communication skillsleadershiporganizational skillsadaptabilityteam collaborationanalytical skillspresentation skillsdecision-makingcross-functional collaborationproblem-solving